• This topic has 1 voice and 0 replies.
Viewing 0 reply threads
  • Author
    Posts
    • #11666
      Amanda
      Keymaster

      FightMND Grant to Fund Phase 2 Study of Investigational Therapy for ALS

      An Australia-based organization called FightMND has granted about $700,000 to biopharmaceutical company to  fund  a randomized, double-blind, placebo-controlled  study on the CuATSM drug.   To learn more about the second phase of the study and for the link for information on the clinical trial read the attached article.

      What do you think about this study? 

Viewing 0 reply threads
  • You must be logged in to reply to this topic.

©2022 KLEO Template a premium and multipurpose theme from Seventh Queen

CONTACT US

We're not around right now. But you can send us an email and we'll get back to you, asap.

Sending

Log in with your credentials

or    

Forgot your details?

Create Account